Powerful and flexible phenotyping options
Flow cytometry can rapidly count, sort, and analyze cell types by creating a fluid suspension of cells with labeled targets to pass through an electronic detection system. This technique is widely used in diagnostics, biomarker detection, evaluating gene expression, and measuring both new and total synthesized DNA, allowing for simultaneous analysis of multiple physical and biochemical properties with one sample.
Our 10-color flow cytometry technique provides a precise characterization of various cell populations, improves detection of low-level abnormalities, and increases success with smaller specimens, delivering more specific and meaningful results for you and your patients.
Flow Cytometry at NeoGenomics
- 10-color flow cytometry - Fast, efficient, and thorough
- Proprietary antibody preparation method - Reduces cell drift and improves consistency in serial testing
- Two options for full leukemia/lymphoma phenotyping - Standard (24 markers) and Extended (31 markers)
- Cost-effective follow-up panels - Highly focused marker sets for monitoring scenarios
- High-sensitivity PNH evaluation - Detection limit of 0.01%
- Complete tech-only options - Increased confidence in results with cytospin images and hands-on regating
Panels are available as global or tech-only services. Whether you are looking to supplement an analysis in progress or monitor known diagnoses, we offer both standard add-on and follow-up panels.
See complete test details
Get a printable test description and specimen requirements
Flow Cytometry for Hematologic Malignancies
Comprehensive panels are useful for the diagnosis of leukemia, lymphoma, and plasma cell neoplasms.
They can also be used for post-treatment follow-up or evaluation of myeloid maturation.
- Standard Leukemia/Lymphoma Panel – 24 markers
- Extended Leukemia/Lymphoma Panel – 31 markers
Add-on panels are available to further aid in the diagnosis and classification of select disease states, supplementing analyses already in progress. Available panels include AML, ALL, CLL, hairy cell, mast cell, plasma cell, PNH, and more.
After diagnosis, follow-up panels are available for monitoring disease or diagnosis of relapse.
Full list of panels includes AML, B-ALL, T-ALL, hairy cell leukemia (HCL), B-Cell and T-Cell lymphoma, and plasma cell.
Minimal residual disease (MRD) testing by flow cytometry is recommended when assessing response to therapy.
Limit of detection for all available flow panels is 0.01%.
- B-ALL MRD Panel
- CLL MRD Panel
- Myeloma MRD Panel
Note: Tech-only option is not available with MRD panels.
NeoGenomics prides itself on our unparalleled customer support team. If you have questions regarding test information, specimen requirements, turnaround times, test add-on, and patient results, please feel free to reach out to a Client Services Advocate at firstname.lastname@example.org.
View our full menu of available Flow Cytometry tests with printable descriptions and specimen requirements.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients